SAN JOSE, Calif. , Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 43 r d annual

Secures New Debt Financing of up to $125M Maturing in 2030  with Plans to Retire $200M in Prior Debt Reports Unaudited Fourth-Quarter Revenue of $29 million and 2024 Revenue of $113 million SAN JOSE, Calif. , Jan. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc.